Skip to main content

Table 1 Study sites

From: A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lymphopenia: RELEASE study protocol

Study site

Principal investigator

Hospital Universitario La Paz

Antonio Pérez Martínez

Hospital Clinic de Barcelona

Álex Soriano Viladomiu

Hospital 12 de Octubre de Madrid

María Liz Paciello Coronel

Hospital Clínic de Valencia

Carlos Solano Vercet

Hospital General Universitario de Alicante

Luis Manuel Hernández Blasco

Hospital Universitario Cruces

Juan José Mateos Mazón

Hospital de Emergencias Enfermera Isabel Zendal

Clara Hernández Blanco